I-Mab
NASDAQ:IMAB

Watchlist Manager
I-Mab Logo
I-Mab
NASDAQ:IMAB
Watchlist
Price: 0.9397 USD -2.01% Market Closed
Market Cap: 76m USD
Have any thoughts about
I-Mab?
Write Note

I-Mab
Short-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

I-Mab
Short-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
I-Mab
NASDAQ:IMAB
Short-Term Debt
ÂĄ30m
CAGR 3-Years
N/A
CAGR 5-Years
-18%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Short-Term Debt
ÂĄ4.7B
CAGR 3-Years
31%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Short-Term Debt
ÂĄ173.1m
CAGR 3-Years
31%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Short-Term Debt
ÂĄ168.4k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Short-Term Debt
ÂĄ3.4B
CAGR 3-Years
23%
CAGR 5-Years
14%
CAGR 10-Years
46%
Imeik Technology Development Co Ltd
SZSE:300896
Short-Term Debt
ÂĄ0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

I-Mab
Glance View

Market Cap
76m USD
Industry
Biotechnology

I-Mab operates as a clinical stage biopharmaceutical company. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2020-01-17.

IMAB Intrinsic Value
0.7454 USD
Overvaluation 21%
Intrinsic Value
Price

See Also

What is I-Mab's Short-Term Debt?
Short-Term Debt
30m CNY

Based on the financial report for Dec 31, 2023, I-Mab's Short-Term Debt amounts to 30m CNY.

What is I-Mab's Short-Term Debt growth rate?
Short-Term Debt CAGR 5Y
-18%

Over the last year, the Short-Term Debt growth was 58%.

Back to Top